Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $37,971,214 |
Sells | 173 | $134,557,766 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Oct 2022 20:57 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 30 Sep 2022 | Sale | 22,500 | 34.06 | 766,350 | D |
04 Oct 2022 20:57 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 30 Sep 2022 | Sale | 22,500 | 31.38 | 706,050 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 100 | 34.39 | 3,439 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 5,350 | 33.57 | 179,600 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 4,550 | 32.8 | 149,240 | D |
07 Oct 2022 18:00 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 06 Oct 2022 | Sale | 22,500 | 39.29 | 884,025 | D |
12 Oct 2022 16:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Oct 2022 | Sale | 5,000 | 37.99 | 189,950 | D |
17 Oct 2022 17:40 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Oct 2022 | Sale | 20,000 | 39.82 | 796,400 | D |
27 Oct 2022 21:23 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2022 | Sale A | 22,500 | 29.18 | 656,550 | D |
27 Oct 2022 21:25 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 25 Oct 2022 | Sale | 12,500 | 44.7155 | 558,944 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 26 Oct 2022 | Sale | 4,762 | 45.03 | 214,433 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 25 Oct 2022 | Sale | 10,653 | 45.0905 | 480,349 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 4,013 | 43.2321 | 173,490 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 23,719 | 42.0299 | 996,907 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 44,440 | 41.1156 | 1,827,177 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 3,693 | 43.2321 | 159,656 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 21,830 | 42.0299 | 917,513 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 40,903 | 41.1156 | 1,681,751 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 20,085 | 44.9002 | 901,821 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 12,537 | 43.9749 | 551,313 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 38,961 | 43.0756 | 1,678,268 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 18,486 | 44.9002 | 830,025 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 11,539 | 43.9749 | 507,426 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 35,860 | 43.0756 | 1,544,691 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,906 | 44.9163 | 220,359 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,515 | 44.9163 | 202,797 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 869 | 41.1204 | 35,734 | I |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 22,096 | 40.279 | 890,005 | I |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 800 | 41.1204 | 32,896 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 20,338 | 40.279 | 819,194 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 500 | 44.02 | 22,010 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 8,900 | 43.47 | 386,883 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 600 | 42.15 | 25,290 | D |
14 Nov 2022 17:26 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Nov 2022 | Sale | 100 | 39.96 | 3,996 | D |
14 Nov 2022 17:26 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Nov 2022 | Sale | 4,900 | 39.41 | 193,109 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 100 | 46.045 | 4,604 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 3,847 | 45.4534 | 174,859 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 15 Nov 2022 | Sale | 3,138 | 45.0423 | 141,343 | D |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 5,179 | 47.6044 | 246,543 | I |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 6,851 | 46.4355 | 318,130 | I |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 4,779 | 47.6044 | 227,501 | D |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 6,322 | 46.4355 | 293,565 | D |
02 Dec 2022 17:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Dec 2022 | Sale | 10,000 | 46.07 | 460,700 | D |
05 Dec 2022 16:36 | AKRO | Akero Therapeutics Inc | SKORPIOS TRUST | Former 10% owner | 01 Dec 2022 | Sale | 1,636,000 | 43.5 | 71,166,000 | I |
13 Dec 2022 20:24 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Dec 2022 | Sale | 402 | 43.77 | 17,596 | D |
13 Dec 2022 20:24 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Dec 2022 | Sale | 4,598 | 43.18 | 198,542 | D |
28 Dec 2022 18:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 27 Dec 2022 | Sale | 12,500 | 49.5687 | 619,609 | D |
29 Dec 2022 17:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 28 Dec 2022 | Sale | 999 | 49.7635 | 49,714 | D |
29 Dec 2022 17:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 27 Dec 2022 | Sale | 19,001 | 49.7663 | 945,609 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 29 Dec 2022 | Sale | 12,293 | 51.3765 | 631,571 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 29 Dec 2022 | Sale | 8,023 | 50.5481 | 405,547 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 28 Dec 2022 | Sale | 1,700 | 50.0038 | 85,006 | D |
05 Jan 2023 17:56 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Jan 2023 | Sale | 8,777 | 54.6383 | 479,560 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 300 | 54.8067 | 16,442 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 3,900 | 54.371 | 212,047 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 800 | 53.0878 | 42,470 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 3,000 | 52.0319 | 156,096 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 3,800 | 50.8194 | 193,114 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 13,200 | 50.1199 | 661,583 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,105 | 51.987 | 57,446 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,313 | 51.1784 | 67,197 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,534 | 49.8901 | 76,531 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,048 | 49.1187 | 51,476 | D |
03 Feb 2023 17:25 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Feb 2023 | Sale | 2,000 | 50.142 | 100,284 | D |
03 Feb 2023 17:25 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Feb 2023 | Sale | 8,155 | 49.6694 | 405,054 | D |
03 Feb 2023 17:25 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Feb 2023 | Sale | 14,845 | 48.5724 | 721,057 | D |
03 Mar 2023 16:21 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Mar 2023 | Sale | 6,700 | 47.1692 | 316,034 | D |
03 Mar 2023 16:21 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Mar 2023 | Sale | 16,035 | 46.5952 | 747,154 | D |
03 Mar 2023 16:21 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Mar 2023 | Sale | 2,265 | 45.5412 | 103,151 | D |
05 Apr 2023 16:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Apr 2023 | Sale | 1,708 | 38.8259 | 66,315 | D |
05 Apr 2023 16:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Apr 2023 | Sale | 23,292 | 37.8783 | 882,261 | D |
03 May 2023 20:28 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 May 2023 | Sale | 3,477 | 45.5045 | 158,219 | D |
03 May 2023 20:28 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 May 2023 | Sale | 21,523 | 45.0049 | 968,640 | D |
23 May 2023 21:55 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 May 2023 | Purchase | 120,000 | 42 | 5,040,000 | I |
23 May 2023 21:55 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 Sep 2023 | Purchase | 400,000 | 26 | 10,400,000 | I |
05 Jun 2023 18:23 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Jun 2023 | Sale | 400 | 45.897 | 18,359 | D |
05 Jun 2023 18:23 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Jun 2023 | Sale | 20,686 | 45.2562 | 936,170 | D |
05 Jun 2023 18:23 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Jun 2023 | Sale | 3,914 | 44.1752 | 172,902 | D |
15 Jun 2023 21:26 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 May 2023 | Purchase A | 120,000 | 42 | 5,040,000 | I |
15 Jun 2023 21:26 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 Sep 2022 | Purchase A | 400,000 | 26 | 10,400,000 | I |
15 Jun 2023 21:29 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jun 2023 | Sale | 591 | 55.16 | 32,600 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Jun 2023 | Sale | 538 | 55.16 | 29,676 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Jun 2023 | Sale | 509 | 55.16 | 28,076 | D |
15 Jun 2023 21:38 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 13 Jun 2023 | Sale | 1,613 | 55.16 | 88,973 | D |
15 Jun 2023 21:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Jun 2023 | Sale | 606 | 55.16 | 33,427 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 1,413 | 56.2966 | 79,547 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 27,462 | 55.08 | 1,512,607 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 49,325 | 54.575 | 2,691,912 | D |
21 Jun 2023 17:47 | AKRO | Akero Therapeutics Inc | HENDERSON JANE | Director | 16 Jun 2023 | Sale | 22,498 | 54.4622 | 1,225,291 | D |
21 Jun 2023 17:47 | AKRO | Akero Therapeutics Inc | HENDERSON JANE | Director | 16 Jun 2023 | Sale | 17,502 | 53.7878 | 941,394 | D |
21 Jun 2023 17:54 | AKRO | Akero Therapeutics Inc | HEYMAN TOMAS J. | Director | 16 Jun 2023 | Sale | 26,000 | 54.6742 | 1,421,529 | D |
22 Jun 2023 17:20 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 20 Jun 2023 | Sale | 20,777 | 55 | 1,142,735 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 500 | 51.4087 | 25,704 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 10,500 | 50.7291 | 532,656 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 22 Jun 2023 | Sale | 11,000 | 52.1759 | 573,935 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Jun 2023 | Sale | 11,349 | 52.2597 | 593,095 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 1,219 | 46.2896 | 56,427 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 5,051 | 45.3615 | 229,121 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 18,730 | 44.6606 | 836,493 | D |
01 Aug 2023 19:52 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 01 Aug 2023 | Purchase | 25,000 | 43.261 | 1,081,525 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)